Label lapse: Brazil suspends ulcer drug
The Brazilian National Health Surveillance Agency (ANVISA) has suspended a batch of Omeprazole due to labelling defects.
Archives for July 11, 2017
AZ announces A$100m expansion of Oz asthma drug plant citing China demand
AstraZeneca has committed A$100m ($76.4m) to expand its manufacturing facility in Sydney Australia, citing growing demand for asthma medications in China.
GE Healthcare and Oritain launch testing service to combat serum fraud
Cell therapy firms will be able to authenticate the foetal bovie serum (FBS) they use through a testing programme launched by GE Healthcare and Oritain.
Mallinckrodt pays $35m to settle alleged oxy reporting and production breaches
The US has told Mallinckrodt LLC to pay $35m (€30m) to settle allegations it broke record keeping rules at its oxycodone plant in New York and failed to notify the DEA of suspicious orders.
Worldwide Clinical Trials taps Medidata for payments solution
Worldwide Clinical Trials has planned its rollout and risk mitigation strategy as it implements Medidata’s Payments Cloud to automate site payments, says CFO.
Catalent re-ups manufacturing deal for Pfizer Liqui-Gels
Catalent Pharma Solutions has signed an exclusive long-term supply agreement with Pfizer.
South Korean CRO adopts Instem tech to automate data collection
Chemon Inc. is automating its preclinical data collection process with Instem’s software solutions and services.
update
UDG acquires healthcare consultancy firm in $32m deal
UDG Healthcare plc has acquired the US-based healthcare industry management consulting firm Vynamic LLC as it looks to augment its commercialization services division.